Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status  Phase of research How it helps Latest publication
Qing Fei Pai Du Tang
Potential treatment - clinical evidence Natural product Antiviral Feb/28/2021
Reduning
Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021
Traditional Indian Ayurvedic treatment regime
Potential treatment - clinical evidence Natural product Antiviral Feb/04/2021
Omega-3 polyunsaturated fatty acids
Potential treatment - clinical evidence Natural product Unknown Mar/29/2021
Yindan Jiedu
Potential treatment - clinical evidence Natural product Antiviral Feb/05/2021
NRICM101
Potential treatment - clinical evidence Natural product Other treatment Nov/19/2020
Vitamin B12
Potential treatment - clinical evidence Natural product Other treatment Aug/18/2020
Ascorbic acid
Potential treatment - clinical evidence Natural product Other treatment Feb/26/2021
Xue Bi Jing
Potential treatment - clinical evidence Natural product Other treatment Sep/10/2020
Mahuang Liu Jun Tang
Potential treatment - clinical evidence Natural product Unknown Sep/14/2020
MIR2911
Potential treatment - clinical evidence Natural product Antiviral Aug/05/2020
Hanshiyi Formula
Potential treatment - clinical evidence Natural product Unknown Aug/13/2020
Da Yuan Yin
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Shuang Huang Lian Kou Fu Ye
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Bu Huan Jin Zheng Qi San
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Shufeng Jiedu
Potential treatment - clinical evidence Natural product Other treatment Oct/22/2020
Tannic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Mar/30/2021
Antipain
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021
rlcv-miR-rL1-28-3p
Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021
Soybean Trypsin Inhibitor
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021